Compile Data Set for Download or QSAR
maximum 50k data
Found 43 Enz. Inhib. hit(s) with all data for entry = 50010735
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098163(5-Methylsulfanyl-4-[2-(4-phenoxy-phenylamino)-thia...)
Affinity DataKi:  60nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098169(5-Methylsulfanyl-4-[2-(4-phenylamino-phenylamino)-...)
Affinity DataKi:  70nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098144(5-Methyl-4-[2-(4-phenoxy-phenylamino)-thiazol-4-yl...)
Affinity DataKi:  80nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098141(4-{2-[4-(4-Chloro-phenoxy)-phenylamino]-thiazol-4-...)
Affinity DataKi:  110nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098127(4-[2-(4-Cyclohexyl-phenylamino)-thiazol-4-yl]-5-me...)
Affinity DataKi:  110nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098139(5-Methylsulfanyl-4-[2-(3,4,5-trimethoxy-phenylamin...)
Affinity DataKi:  160nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098132(5-Methyl-4-(2-phenylamino-thiazol-4-yl)-thiophene-...)
Affinity DataKi:  170nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098147(4-[2-(4-Benzyloxy-phenylamino)-thiazol-4-yl]-5-met...)
Affinity DataKi:  180nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098131(5-Methylsulfanyl-4-[2-(4-phenylazo-phenylamino)-th...)
Affinity DataKi:  180nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098133(4-[2-(4-Benzyl-phenylamino)-thiazol-4-yl]-5-methyl...)
Affinity DataKi:  180nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098166(5-Methylsulfanyl-4-(2-phenylamino-thiazol-4-yl)-th...)
Affinity DataKi:  200nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098149(4-[2-(2-Fluoro-phenylamino)-thiazol-4-yl]-5-methyl...)
Affinity DataKi:  240nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098164(4-[2-(4-Methoxy-phenylamino)-thiazol-4-yl]-5-methy...)
Affinity DataKi:  280nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098151(4-[2-(2-Bromo-phenylamino)-thiazol-4-yl]-5-methyls...)
Affinity DataKi:  280nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098150(4-[2-(4-Chloro-2-methyl-phenylamino)-thiazol-4-yl]...)
Affinity DataKi:  280nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098142(4-[2-(3-Methoxy-phenylamino)-thiazol-4-yl]-5-methy...)
Affinity DataKi:  280nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098158(4-[2-(2,3-Dimethyl-phenylamino)-thiazol-4-yl]-5-me...)
Affinity DataKi:  280nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098140(4-[2-(4-Dimethylamino-phenylamino)-thiazol-4-yl]-5...)
Affinity DataKi:  310nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098137(2-amidino-4-iodobenzothiophene | 4-Iodo-benzo[b]th...)
Affinity DataKi:  320nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098143(5-Methylsulfanyl-4-[2-(3-phenyl-propylamino)-thiaz...)
Affinity DataKi:  350nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098152(5-Methylsulfanyl-4-{2-[4-(piperidine-1-sulfonyl)-p...)
Affinity DataKi:  400nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098138(4-[2-(2-Bromo-4-methyl-phenylamino)-thiazol-4-yl]-...)
Affinity DataKi:  430nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098162(4-[2-(3-Chloro-2-methyl-phenylamino)-thiazol-4-yl]...)
Affinity DataKi:  440nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098153(4-{2-[4-(4-Methoxy-phenyl)-piperazin-1-yl]-thiazol...)
Affinity DataKi:  480nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098156(5-Methylsulfanyl-4-[2-(naphthalen-1-ylamino)-thiaz...)
Affinity DataKi:  500nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098145(4-[2-(Benzo[1,3]dioxol-5-ylamino)-thiazol-4-yl]-5-...)
Affinity DataKi:  520nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098155(4-[2-(4-Methyl-benzylamino)-thiazol-4-yl]-5-methyl...)
Affinity DataKi:  640nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098148(4-[2-(2,5-Dimethoxy-phenylamino)-thiazol-4-yl]-5-m...)
Affinity DataKi:  660nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098128(4-[2-(2-Isopropyl-phenylamino)-thiazol-4-yl]-5-met...)
Affinity DataKi:  700nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098160(5-Methylsulfanyl-4-{2-[4-(5-trifluoromethyl-pyridi...)
Affinity DataKi:  910nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098129(2-{3-[4-(5-Carbamimidoyl-2-methylsulfanyl-thiophen...)
Affinity DataKi:  1.02E+3nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098136(5-Methylsulfanyl-4-[2-(2,4,5-trimethyl-phenylamino...)
Affinity DataKi:  1.10E+3nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098135(5-Methyl-4-[2-(3,4,5-trimethoxy-phenylamino)-thiaz...)
Affinity DataKi:  1.11E+3nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098146(4-[2-(Benzhydryl-amino)-thiazol-4-yl]-5-methylsulf...)
Affinity DataKi:  1.18E+3nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098154(5-Methylsulfanyl-4-[2-(2-morpholin-4-yl-ethylamino...)
Affinity DataKi:  1.40E+3nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098165(4-[2-(2-Chloro-phenylamino)-thiazol-4-yl]-5-methyl...)
Affinity DataKi:  1.46E+3nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098168(4-[2-(2,6-Dichloro-phenylamino)-thiazol-4-yl]-5-me...)
Affinity DataKi:  1.50E+3nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098130(5-Methylsulfanyl-4-[2-(2-piperidin-1-yl-ethylamino...)
Affinity DataKi:  1.60E+3nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098159(4-(2-Amino-thiazol-4-yl)-5-methyl-thiophene-2-carb...)
Affinity DataKi:  1.62E+3nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098157(4-{2-[4-(3-Methoxy-phenyl)-piperazin-1-yl]-thiazol...)
Affinity DataKi:  1.84E+3nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098161(4-{2-[4-(2-Fluoro-phenyl)-piperazin-1-yl]-thiazol-...)
Affinity DataKi:  3.06E+3nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098134(4-(2-Amino-thiazol-4-yl)-5-methylsulfanyl-thiophen...)
Affinity DataKi:  3.90E+3nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50098167(5-Mercaptomethyl-thiophene-2-carboxamidine | CHEMB...)
Affinity DataKi:  6.00E+3nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed